So far, only a few therapeutic agents have shown efficacy in metastatic disease: fluoropyrimidines, oxaliplatin, irinotecan, anti-epidermal growth factor receptor (anti-EGFR) drugs as cetuximab and panitumumab, and anti-angiogenic drugs. Here, EGFR is linked to metastatic neoplasm.